Moderna’s stock jumps after biotech raises sales outlook
The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
